Anemia in IBD: the overlooked villain
- PMID: 10833075
- DOI: 10.1097/00054725-200005000-00013
Anemia in IBD: the overlooked villain
Abstract
During the past decade relevant progress has been made in the understanding and treatment of IBD-associated anemia. Effective replacement of iron deficits has become safe by using novel intravenous iron preparations such as iron sucrose. The ability of erythropoietin to interfere with key mechanisms of myelosuppression in anemia of chronic diseases also benefits patients with IBD-associated anemia. Concerns about cost effectiveness have been raised and weighed against the potential improvement in quality of life. Gastroenterologists who are caring for IBD patients should be concerned with low hemoglobin levels, since the quality of life in these patients can be as low as in anemic patients with advanced cancer. Also provided is a structured approach to cost-effective therapy.
Similar articles
-
Anemia and inflammatory bowel diseases.World J Gastroenterol. 2009 Oct 7;15(37):4659-65. doi: 10.3748/wjg.15.4659. World J Gastroenterol. 2009. PMID: 19787829 Free PMC article. Review.
-
Stimulating erythropoiesis in inflammatory bowel disease associated anemia.World J Gastroenterol. 2007 Sep 28;13(36):4798-806. doi: 10.3748/wjg.v13.i36.4798. World J Gastroenterol. 2007. PMID: 17828809 Free PMC article. Review.
-
[Research progress of anemia associated with inflammatory bowel diseases].Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Jun;15(6):644-7. Zhonghua Wei Chang Wai Ke Za Zhi. 2012. PMID: 22736141 Review. Chinese.
-
Recombinant erythropoietin for anemia in inflammatory bowel disease.N Engl J Med. 1996 Sep 5;335(10):751-2. doi: 10.1056/NEJM199609053351016. N Engl J Med. 1996. PMID: 8786771 No abstract available.
-
Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia.Am J Gastroenterol. 2001 Aug;96(8):2382-7. doi: 10.1111/j.1572-0241.2001.04094.x. Am J Gastroenterol. 2001. PMID: 11513178 Clinical Trial.
Cited by
-
The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease.Inflamm Bowel Dis. 2015 Jul;21(7):1587-93. doi: 10.1097/MIB.0000000000000417. Inflamm Bowel Dis. 2015. PMID: 25933393 Free PMC article.
-
Intravenous iron in digestive diseases: a clinical (re)view.Ther Adv Chronic Dis. 2010 Mar;1(2):67-75. doi: 10.1177/2040622310373675. Ther Adv Chronic Dis. 2010. PMID: 23251730 Free PMC article.
-
Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology.Biomed Res Int. 2015;2015:728925. doi: 10.1155/2015/728925. Epub 2015 Feb 1. Biomed Res Int. 2015. PMID: 25705682 Free PMC article.
-
Common Mistakes in Managing Patients with Inflammatory Bowel Disease.J Clin Med. 2024 Aug 14;13(16):4795. doi: 10.3390/jcm13164795. J Clin Med. 2024. PMID: 39200937 Free PMC article. Review.
-
Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort.J Clin Gastroenterol. 2016 Sep;50(8):638-43. doi: 10.1097/MCG.0000000000000417. J Clin Gastroenterol. 2016. PMID: 26485103 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous